N-(6,6-dimethyl-5-((1-methylpiperidin-4-yl)carbonyl)-1,4,5,6-tetrahydropyrrolo(3,4-c)pyrazol-3-yl)-3-methylbutanamide,
PHA 793887,
PHA-793887,
PHA793887,
PHA-793887,
718630-59-2,
3-Methyl-N-[1,4,5,6-tetrahydro-6,6-dimethyl-5-[(1-methyl-4-piperidinyl)carbonyl]pyrrolo[3,4-c]pyrazol-3-yl]butanamide,
UNII-MKS45S912B,
N-(6,6-dimethyl-5-(1-methylpiperidine-4-carbonyl)-1,4,5,6-tetrahydropyrrolo[3,4-c]pyrazol-3-yl)-3-methylbutanamide,
MKS45S912B,
CHEMBL1230607,
PHA 793887,
C19H31N5O2,
N-(6,6-Dimethyl-5-(1-methylpiperidine-4-carbonyl)-1,4,5,6-tetrahydropyrrolo(3,4-C)pyrazol-3-yl)-3-methylbutanamide,
N-[6,6-dimethyl-5-(1-methylpiperidine-4-carbonyl)-1,4-dihydropyrrolo[3,4-c]pyrazol-3-yl]-3-methylbutanamide,
N-{6,6-Dimethyl-5-[(1-methylpiperidin-4-yl)carbonyl]-1,4,5,6-tetrahydropyrrolo[3,4-c]pyrazol-3-yl}-3-methylbutanamide,
MLS006010173,
SCHEMBL5110328,
CHEBI:91371,
CTK5D5171,
KS-00000XGS,
DTXSID50222134,
BCPP000110,
HMS3265M13,
HMS3265M14,
HMS3265N13,
HMS3265N14,
HMS3654B16,
AOB87190,
BCP02036,
EX-A2134,
ABP000550,
BDBM50378657,
PHA793887,
ZINC52509437,
AKOS015995002,
DB12686,
QC-8186,
RL04741,
SB19463,
PHA-793887/,
NCGC00263168-01,
NCGC00263168-06,
AK474119,
AS-19371,
Butanamide, 3-methyl-N-(1,4,5,6-tetrahydro-6,6-dimethyl-5-((1-methyl-4-piperidinyl)carbonyl)pyrrolo(3,4-C)pyrazol-3-yl)-,
HY-11001,
SC-96644,
SMR004701281,
DB-074487,
FT-0660374,
S1487,
SW220252-1,
X7380,
J3.661.625C,
PHA793887, PHA-793887,
S-7775,
J-512917,
BRD-K64800655-001-01-7,
N-[6,6-dimethyl-5-(1-methylpiperidine-4-carbonyl)-1H,4H-pyrrolo[3,4-c]pyrazol-3-yl]-3-methylbutanamide,
D0P1CV,
cc-404,
ACN-052754,
CS-0020,
A5459,
A10716,
Cyclin-dependent kinase inhibitor (cancer), Nerviano,